Kraig Biocraft Laboratories, Inc. KBLB
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -58.92% | -13.60% | -6.60% | 4.77% | 34.53% |
| Total Depreciation and Amortization | 11.49% | -36.21% | -37.45% | 120.50% | 86.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,574.06% | 46.71% | 15.82% | -38.03% | -105.45% |
| Change in Net Operating Assets | -10.58% | 5.82% | 26.36% | 10.47% | 4.48% |
| Cash from Operations | -18.84% | -5.61% | 2.72% | -11.95% | -8.86% |
| Capital Expenditure | -453.75% | -364.29% | -28.57% | -- | -25.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 101.22% | -- | -- | -- | -91.48% |
| Cash from Investing | 80.83% | 10,195.24% | 10,530.95% | -- | -91.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2,303.85% | -518.81% | -255.11% | 0.40% | 91.33% |
| Issuance of Common Stock | 427.75% | 2,325.21% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | -- | -- | -- |
| Cash from Financing | 422.42% | 2,765.36% | 7,110.80% | 3,816.33% | 1,501.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 454.06% | 251.11% | 159.45% | 122.04% | -969.07% |